Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs Misoprostol in Hysteroscopic Myomectomy
NCT03930069Phase 3Completed
- Sponsor
- Zagazig University
- Start
- May 2016
- Primary completion
- Jan 2017
- Modality
- Peptides
01
Overview
Phase 3, randomised, open-label trial of vasopressin in uterine leiomyoma (UL) (2 arms), sponsored by Zagazig University. Primary endpoints: Intraoperative Blood Loss, Operative Time and 1 more. Started May 2016; status: completed.
02
Drugs
vasopressin
03
Conditions
uterine leiomyoma (UL)
Beyond the preview
Go deeper on NCT03930069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03930069.